CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President and CEO sold 13,052 shares at $21.04 ($274,614)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $21.11 ($52,775)
- 4 Open-market sale Director sold 5,000 shares at $22.29 ($111,426)
- 4 Option exercise Chief Medical Officer acquired 15,117 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise CSO, Head Res.&Non-Clin. Dev. acquired 5,130 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.58 ($51,450)
- 4 Open-market sale President and CEO sold 14,340 shares at $20.60 ($295,404)
- 8-K Event Executive or director change
- 8-K Event Other events
- CT ORDER Other Confidential Order
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale President and CEO sold 14,342 shares at $19.86 ($284,832)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.00 ($50,000)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Open-market sale President and CEO sold 19,120 shares at $24.13 ($461,366)
Page 29 of 41 · 801 filings